Mitochondrial Function Inhibition

Mitochondrial function inhibition involves targeting key components of the electron transport chain—most notably complexes I and IV—to disrupt ATP production, alter redox balance through increased ROS generation, disturb membrane potential dynamics, and potentially induce cell death pathways. These mechanisms are central both for understanding toxicity profiles of certain drugs/compounds as well as for developing therapeutic strategies that exploit metabolic vulnerabilities in diseases such as cancer or diabetes.

Direct enzymatic inhibition of electron transport chain complexes, leading to decreased ATP production, increased ROS, and altered mitochondrial membrane potential.